The incubator is designed to draw cell and gene therapy researchers and drugmakers to work at the hub, where they can develop ...
The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...
Gov. Kathy Hochul announced plans to build a $430 million New York BioGenesis Park — a cell and gene therapy lab — in Lake ...
The regulator agreed to allow Sangamo Therapeutics to use data to seek accelerated approval for its Fabry gene therapy ...
Eye drug maker Ocuphire Pharma is acquiring gene therapy developer Opus Genetics in an all-stock transaction that will see ...
Gov. Kathy Hochul on Tuesday announced a $150 million investment in a new state-of-the-art cell and gene therapy hub to be ...
Ocuphire Pharma has announced the acquisition of Opus Genetics to develop gene therapies for inherited retinal diseases (IRDs ...
The MIND diet was associated with slower cognitive decline in both Black and white older adults, but relationships appeared ...
The significance of this is that it brings about the ability to obtain FDA approval for this AAV gene therapy without the need to run a phase 3 study. Even better, it has another positive worth ...
The biotech engaged with the FDA on alternative pathways to approval after seeing safety and efficacy data from the phase 1/2 ...
Visiting Nassau County on Tuesday, Gov. Kathy Hochul announced plans for the New York BioGenesis Park, a $430 million, ...
Medpage Today on MSN1d
Evidence of Durable Vision Improvement With Gene Therapy for Retinitis PigmentosaCHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback